登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C20H18ClNNa2O7 · xH2O
化学文摘社编号:
分子量:
465.79 (anhydrous basis)
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
CL 316,243 水合物, ≥98% (HPLC), powder
SMILES string
O.[Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C([O-])=O)C([O-])=O)NC[C@H](O)c3cccc(Cl)c3
InChI
1S/C20H20ClNO7.2Na.H2O/c1-11(22-10-15(23)13-3-2-4-14(21)9-13)7-12-5-6-16-17(8-12)29-20(28-16,18(24)25)19(26)27;;;/h2-6,8-9,11,15,22-23H,7,10H2,1H3,(H,24,25)(H,26,27);;;1H2/q;2*+1;/p-2/t11-,15+;;;/m1.../s1
InChI key
BFEWLXURNRQQLY-BELDDISZSA-L
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
H2O: 10 mg/mL, clear
originator
Wyeth
storage temp.
room temp
Quality Level
Gene Information
human ... ADRB3(155)
正在寻找类似产品? 访问 产品对比指南
Application
CL 316,243 水合物可用于:
- 作为β-激动剂,用于小鼠注射,研究其对哺乳动物主要促进子超家族结构域表达的影响-包含蛋白 (Mfsd2a)
- 作为肾上腺素能激动剂来刺激肾上腺素能反应,研究小鼠棕色、米色和白色脂肪组织的代谢活性
- 作为 β3-肾上腺素能激动剂,用于体内 注射脂解性挑战
Biochem/physiol Actions
β 肾上腺素能受体可以在许多组织中表达,例如心脏、脂肪组织、结肠和其他组织。它与多种不同的生物学功能有关。 β 肾上腺素能受体可以作为治疗2型糖尿病、心力衰竭、恶病质、肥胖、代谢紊乱,以及与膀胱、结肠和恶性肿瘤生长有关问题的靶向。抑郁和焦虑也可以利用β肾上腺素受体治疗。CL 316,243通过β肾上腺素能受体可以具有抗糖尿病作用。它是强力的脂肪分解刺激剂,还能激活 β下丘脑区域神经元上的12-3-肾上腺素受体,对食欲的中枢调节很重要。
CL 316,243是一种β3 肾上腺素受体激动剂和减肥药。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Metabolic activity of brown,?beige,? and white adipose tissues in response to chronic adrenergic stimulation in male mice
Labbe SM, et al.
American Journal of Physiology. Endocrinology and Metabolism, 311(1), E260-E268 (2016)
Y Igawa et al.
British journal of pharmacology, 126(3), 819-825 (1999-04-03)
The possible existence of a beta3-adrenergic receptor (beta3-AR) in the human detrusor muscle was investigated by in vitro functional studies and analysis of mRNA expression. Isoprenaline, noradrenaline and adrenaline each produced a concentration-dependent relaxation of the human detrusor. The rank
Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis
Angers M, et al.
The Biochemical Journal, 416(3), 347-355 (2008)
beta3-Adrenoceptor agonists and (antagonists as) inverse agonists: history, perspective, constitutive activity, and stereospecific binding
Methods in Enzymology, 484, 197-230 (2010)
Intracerebroventricular administration of the beta3-adrenoceptor agonist CL 316243 causes Fos immunoreactivity in discrete regions of rat hypothalamus
Castillo-Melendez M, et al.
Neuroscience Letters, 290(3), 161-164 (2000)
商品
DISCOVER Bioactive Small Molecules for Neuroscience
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持